Colloquium research group Community Genetics
Optimizing the academic route to patient access of advanced therapies - Eduard Siemerink
Student Management, Policy Analysis & Entrepreneurship (MPA) major Science in Society (SiS) as part of master Drug Discovery & Safety (DDS)
Ophthalmogenetics is developing a cell therapy for the treatment of macula degeneration. Several stakeholders mainly in the fields of ethics, regulation and reimbursement were interviewed to obtain an understanding of the facilitators and barriers in the route to patient access. Recommendations are provided that will support academics to successfully deliver an advanced therapy medicinal product (ATMP) to the patient.
Link to the meeting:
Microsoft Teams-vergadering
Klik hier om deel te nemen aan de vergadering
vergaderings-id: 346 125 601 202
Wachtwoordcode: JMzuTg
Teams downloaden | Deelnemen op het web
or more information, please contact:
Carla van El PhD | Senior Researcher
Section Community Genetics, Department of Human Genetics/ Amsterdam Public Health research institute
cg.vanel@amsterdamumc.nl
Carla van El — Amsterdam UMC - Vrije Universiteit Amsterdam (vumc.nl)
ORCID https://orcid.org/0000-0003-2201-2320
www.amsterdamumc.nl